Printer Friendly Version

    Peter Fallon is a seasoned professional with outstanding judgment, and a proven ability to develop patent portfolios and provide strategic intellectual property counseling. He also provides opinions to industry leading corporations in the fields of energy, pharmaceuticals, high-technology materials, advanced chemical manufacturing, oilfield services and products, high performance ultra-nanocrystalline diamond technology, electro-mechanical hydraulic actuators, and geospatial technologies. Peter has extensive U.S. and foreign filed patent prosecution experience including appeals, reexaminations and reissue proceedings, interference and derivation practice, and Patent Trial and Appeal Board proceedings. Peter’s patent infringement litigation experience includes discovery, fact depositions, expert reports and depositions, motion practice and trial experience.

    Peter has experience counseling clients in all issues related to patent prosecution, including but not limited to preparing and filing patent applications. As well as, preparing Freedom to Operate, validity, and non-infringement opinions, and Paragraph IV Certification Notice Letters for international and domestic pharmaceutical companies. His experience includes representing pharmacy benefit management (PBMs) companies and other health care organizations in a range of corporate and transactional matters and in regulatory and administrative proceedings. Peter's legal experience includes lead roles in corporate and entity formation, managed care contracting, joint ventures, outsourcing and commercial contracting.

    Read More

    Find News, Events, Notable Matters, and More

    Showing Results for



    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.